FOBT still key for bowel screening
Doctors are being urged to ignore the mixed messages about a new blood test for bowel cancer screening and stick to the gold standard FOBT.
The advice comes after news last week that a DNA test developed by Australian researchers would revolutionise bowel cancer screening.
The test, which is performed on a blood sample, detected 65% of bowel cancer cases, its developers reported at Digestive Diseases Week in Chicago, last week.
The test was designed to be used as an adjunct to FOBT,